Pretreatment high-resolution rectal MRI and treatment response to neoadjuvant chemoradiation

Diseases of the Colon and Rectum

Volumn 55, Issue 4, 2012, Pages 371-377

  Chang, George J ^a   You, Y Nancy ^a   Kaur, Harmeet ^a   Hu, Chung Yuan ^a   Rodriguez Bigas, Miguel A ^a   Skibber, John M ^a   Ernst, Randy D ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Magnetic resonance imaging; Neoadjuvant therapy; Rectal cancer; Staging

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CURCUMIN; ERLOTINIB;

ADULT; ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER SIZE; CANCER STAGING; CHEMORADIOTHERAPY; COHORT ANALYSIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PROBABILITY; RECTUM CANCER; RECTUM RESECTION; TERTIARY HEALTH CARE; TREATMENT RESPONSE; UNIVERSITY HOSPITAL;

CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROCTOSCOPY; PROGNOSIS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; ROC CURVE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84859755352     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0b013e31824678e3     Document Type: Article

References (18)

1. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-1740.
2. Maas M, Nelemans PJ, Valentini V, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data. Lancet Oncol. 2010;11:835-844.
3. Das P, Skibber JM, Rodriguez-Bigas MA, et al. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol. 2006;29:219-224. (Pubitemid 44270928)
4. Garcia-Aguilar J, Hernandez de Anda E, Sirivongs P, Lee SH, Madoff RD, Rothenberger DA. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum. 2003;46:298-304. (Pubitemid 36331646)
5. Borschitz T, Wachtlin D, Mohler M, Schmidberger H, Junginger T. Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Ann Surg Oncol. 2008;15:712-720.
6. Habr-Gama A, Perez RO, Nadalin W, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: Long-term results. Ann Surg. 2004;240: 711-718. (Pubitemid 39281293)
7. Chua YJ, Barbachano Y, Cunningham D, et al. Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: A phase 2 trial. Lancet Oncol. 2010;11:241-248.
8. Fernandez-Martos C, Pericay C, Aparicio J, et al. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging- defined, locally advanced rectal cancer: Grupo cancer de recto 3 study. J Clin Oncol. 2010;28:859-865.
9. Heald RJ, O'Neill BDP, Moran B, et al. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: Prospective observational study. BMJ. 2006;333:779.
10. Smith NJ, Barbachano Y, Norman AR, Swift RI, Abulafi AM, Brown G. Prognostic significance of magnetic resonance imaging- detected extramural vascular invasion in rectal cancer. Br J Surg. 2008;95:229-236.
11. Taylor FG, Swift RI, Blomqvist L, Brown G. A systematic approach to the interpretation of preoperative staging MRI for rectal cancer. AJR Am J Roentgenol. 2008;191:1827-1835.
12. Brown G, Richards CJ, Bourne MW, et al. Morphologic predictors of lymph node status in rectal cancer with use of highspatial- resolution MR imaging with histopathologic comparison. Radiology. 2003;227:371-377. (Pubitemid 36514749)
13. Taylor FG, Quirke P, Heald RJ, et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: A prospective, multicenter, European study. Ann Surg. 2011;253: 711-719.
14. Tsai CJ, Crane CH, Skibber JM, et al. Number of lymph nodes examined and prognosis among pathologically lymph nodenegative patients after preoperative chemoradiation therapy for rectal adenocarcinoma. Cancer. 2011;117:3713-3722.
15. Silberfein EJ, Kattepogu KM, Hu CY, et al. Long-term survival and recurrence outcomes following surgery for distal rectal cancer. Ann Surg Oncol. 2010;17:2863-2869.
16. Chang GJ, Rodriguez-Bigas MA, Eng C, Skibber JM. Lymph node status after neoadjuvant radiotherapy for rectal cancer is a biologic predictor of outcome. Cancer. 2009;115:5432-5440.
17. Engelen SM, Beets-Tan RG, Lahaye MJ, et al. MRI after chemoradiotherapy of rectal cancer: A useful tool to select patients for local excision. Dis Colon Rectum. 2010;53:979-986.
18. Lambregts DM, Vandecaveye V, Barbaro B, et al. Diffusionweighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: A multicenter study. Ann Surg Oncol. 2011;18:2224-2231.